Neoplasms Colorectal clinical trials

Explore recruiting neoplasms colorectal clinical trials.

Recruiting neoplasms colorectal studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Neoplasms Colorectal trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 1/2 open-label, multicenter study of oral GSK5460025 alone or in combination with other anti-cancer agents in adult participants with Mismatch Repair-deficient (dMMR) or Microsatellite Instability-High (MSI-H) solid tumors.

Italy, Denmark, Spain, Sweden, Netherlands, France

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

A Phase 1/2 First-Time-in-Human, open-label, multicenter, dose escalation and expansion study of the oral DNA Helicase Werner Inhibitor (WRNi) GSK4418959 alone or in combination with other anti-cancer agents in adult participants with Mismatch Repair-deficient (dMMR) or Microsatellite Instability-High (MSI-H) solid tumors (SYLVER)

Netherlands, Spain, Belgium

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

A Study of LY4257496 in Participants With Cancer (OMNIRAY)

Germany

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

A Study of LY4337713 in Participants With FAP-Positive Solid Tumors (FiREBOLT)

Germany, Netherlands

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

Neoplasms Colorectal trials by city

Neoplasms Colorectal in Toronto Neoplasms Colorectal in Vancouver Neoplasms Colorectal in Montreal Neoplasms Colorectal in Calgary Neoplasms Colorectal in Edmonton Neoplasms Colorectal in Ottawa Neoplasms Colorectal in Winnipeg Neoplasms Colorectal in Quebec City Neoplasms Colorectal in Hamilton Neoplasms Colorectal in Kitchener Neoplasms Colorectal in London Neoplasms Colorectal in Halifax Neoplasms Colorectal in New York Neoplasms Colorectal in Los Angeles Neoplasms Colorectal in Chicago Neoplasms Colorectal in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease